US Stock MarketDetailed Quotes

West Pharmaceutical Services (WST)

Watchlist

269.810
+3.310+1.24%

Close Apr 16 16:00 ET

269.810
0.0000.00%

Pre 04:00 ET

19.45BMarket Cap39.74P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

West Pharmaceutical Services (WST) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

15.52%754.8M

32.09%251.1M

9.49%197.2M

7.33%177.1M

9.48%129.4M

-15.85%653.4M

-20.49%190.1M

-21.73%180.1M

-2.48%165M

-14.41%118.2M

Net income from continuing operations

0.20%493.7M

1.54%132.1M

2.94%140M

18.42%131.8M

-22.12%89.8M

-16.97%492.7M

-5.04%130.1M

-15.69%136M

-28.24%111.3M

-17.64%115.3M

Operating gains losses

35.71%-9.9M

----

-196.15%-15.4M

----

Depreciation and amortization

10.30%171.4M

15.48%47M

6.97%43M

6.43%41.4M

12.36%40M

13.18%155.4M

13.37%40.7M

12.61%40.2M

14.08%38.9M

12.66%35.6M

Deferred tax

-291.43%-13.7M

----

-109.33%-3.5M

----

Other non cash items

57.45%-2M

-102.00%-100K

261.90%3.4M

17.95%-3.2M

43.24%-2.1M

-570.00%-4.7M

-65.52%5M

-90.91%-2.1M

33.90%-3.9M

43.08%-3.7M

Change In working capital

2,651.72%79.8M

247.66%81.7M

2,200.00%2.1M

-129.08%-4.1M

100.29%100K

114.22%2.9M

-12.64%23.5M

-100.40%-100K

155.73%14.1M

26.07%-34.6M

-Change in receivables

111.73%6.9M

----

-1,570.00%-58.8M

----

-Change in inventory

-249.52%-62.8M

----

411.11%42M

----

-Change in payables and accrued expense

517.24%17.9M

----

-34.09%2.9M

----

-Change in other current assets

267.24%9.7M

----

72.77%-5.8M

----

-Change in other working capital

378.32%108.1M

----

276.67%22.6M

----

Cash from discontinued investing activities

Operating cash flow

15.52%754.8M

32.09%251.1M

9.49%197.2M

7.33%177.1M

9.48%129.4M

-15.85%653.4M

-20.49%190.1M

-21.73%180.1M

-2.48%165M

-14.41%118.2M

Investing cash flow

Cash flow from continuing investing activities

24.50%-285.9M

27.39%-76.1M

22.90%-63.3M

25.69%-75.2M

21.30%-71.3M

-2.71%-378.7M

3.68%-104.8M

14.21%-82.1M

-23.26%-101.2M

-10.35%-90.6M

Capital expenditure reported

24.16%-285.9M

27.45%-76.1M

22.14%-63.3M

24.95%-75.2M

21.30%-71.3M

-4.14%-377M

3.50%-104.9M

15.14%-81.3M

-32.89%-100.2M

-10.35%-90.6M

Net other investing changes

----

74.63%-1.7M

200.00%100K

-900.00%-800K

----

Cash from discontinued investing activities

Investing cash flow

24.50%-285.9M

27.39%-76.1M

22.90%-63.3M

25.69%-75.2M

21.30%-71.3M

-2.71%-378.7M

3.68%-104.8M

14.21%-82.1M

-23.26%-101.2M

-10.35%-90.6M

Financing cash flow

Cash flow from continuing financing activities

70.27%-185.1M

83.02%-11.7M

82.14%-11.5M

93.17%-14.9M

45.76%-147M

-35.47%-622.6M

63.64%-68.9M

-188.79%-64.4M

-23.47%-218.3M

-281.69%-271M

Net issuance payments of debt

96.01%-1.1M

-200.00%-300K

91.43%-300K

98.71%-300K

71.43%-200K

-1,050.00%-27.6M

85.71%-100K

-483.33%-3.5M

-4,560.00%-23.3M

-16.67%-700K

Net common stock issuance

75.86%-136.8M

99.63%-200K

99.81%-100K

99.73%-500K

50.07%-136M

-25.58%-566.6M

69.17%-54.6M

-86.48%-52.4M

-7.34%-187.2M

-280.45%-272.4M

Cash dividends paid

-3.55%-61.2M

-3.27%-15.8M

-4.14%-15.1M

-3.42%-15.1M

-3.40%-15.2M

-3.68%-59.1M

-3.38%-15.3M

-3.57%-14.5M

-3.55%-14.6M

-4.26%-14.7M

Proceeds from stock option exercised by employees

-44.34%18.2M

48.39%4.6M

-33.33%4M

-23.53%5.2M

-73.81%4.4M

-35.88%32.7M

0.00%3.1M

-70.59%6M

-44.26%6.8M

9.80%16.8M

Net other financing activities

-110.00%-4.2M

--0

----

---2M

----

Cash from discontinued financing activities

Financing cash flow

70.27%-185.1M

83.02%-11.7M

82.14%-11.5M

93.17%-14.9M

45.76%-147M

-35.47%-622.6M

63.64%-68.9M

-188.79%-64.4M

-23.47%-218.3M

-281.69%-271M

Net cash flow

Beginning cash position

-43.25%484.6M

28.03%628.5M

14.23%509.7M

-32.83%404.2M

-43.25%484.6M

-4.52%853.9M

-45.37%490.9M

-43.97%446.2M

-32.10%601.8M

-4.52%853.9M

Current changes in cash

181.58%283.8M

895.73%163.3M

264.29%122.4M

156.31%87M

63.48%-88.9M

-571.62%-347.9M

127.70%16.4M

-70.03%33.6M

-72.24%-154.5M

-1,522.67%-243.4M

Effect of exchange rate changes

207.01%22.9M

97.80%-500K

-132.43%-3.6M

1,781.82%18.5M

197.70%8.5M

-287.72%-21.4M

-256.55%-22.7M

213.27%11.1M

-266.67%-1.1M

-224.29%-8.7M

End cash Position

63.29%791.3M

28.03%628.5M

14.23%509.7M

-32.83%404.2M

-43.25%484.6M

-45.37%490.9M

-43.97%446.2M

-32.10%601.8M

Free cash flow

69.65%468.9M

105.40%175M

35.53%133.9M

57.25%101.9M

110.51%58.1M

-33.32%276.4M

-34.66%85.2M

-26.43%98.8M

-30.92%64.8M

-50.71%27.6M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	15.52%754.8M	32.09%251.1M	9.49%197.2M	7.33%177.1M	9.48%129.4M	-15.85%653.4M	-20.49%190.1M	-21.73%180.1M	-2.48%165M	-14.41%118.2M
Net income from continuing operations	0.20%493.7M	1.54%132.1M	2.94%140M	18.42%131.8M	-22.12%89.8M	-16.97%492.7M	-5.04%130.1M	-15.69%136M	-28.24%111.3M	-17.64%115.3M
Operating gains losses	35.71%-9.9M	----	----	----	----	-196.15%-15.4M	----	----	----	----
Depreciation and amortization	10.30%171.4M	15.48%47M	6.97%43M	6.43%41.4M	12.36%40M	13.18%155.4M	13.37%40.7M	12.61%40.2M	14.08%38.9M	12.66%35.6M
Deferred tax	-291.43%-13.7M	----	----	----	----	-109.33%-3.5M	----	----	----	----
Other non cash items	57.45%-2M	-102.00%-100K	261.90%3.4M	17.95%-3.2M	43.24%-2.1M	-570.00%-4.7M	-65.52%5M	-90.91%-2.1M	33.90%-3.9M	43.08%-3.7M
Change In working capital	2,651.72%79.8M	247.66%81.7M	2,200.00%2.1M	-129.08%-4.1M	100.29%100K	114.22%2.9M	-12.64%23.5M	-100.40%-100K	155.73%14.1M	26.07%-34.6M
-Change in receivables	111.73%6.9M	----	----	----	----	-1,570.00%-58.8M	----	----	----	----
-Change in inventory	-249.52%-62.8M	----	----	----	----	411.11%42M	----	----	----	----
-Change in payables and accrued expense	517.24%17.9M	----	----	----	----	-34.09%2.9M	----	----	----	----
-Change in other current assets	267.24%9.7M	----	----	----	----	72.77%-5.8M	----	----	----	----
-Change in other working capital	378.32%108.1M	----	----	----	----	276.67%22.6M	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	15.52%754.8M	32.09%251.1M	9.49%197.2M	7.33%177.1M	9.48%129.4M	-15.85%653.4M	-20.49%190.1M	-21.73%180.1M	-2.48%165M	-14.41%118.2M
Investing cash flow
Cash flow from continuing investing activities	24.50%-285.9M	27.39%-76.1M	22.90%-63.3M	25.69%-75.2M	21.30%-71.3M	-2.71%-378.7M	3.68%-104.8M	14.21%-82.1M	-23.26%-101.2M	-10.35%-90.6M
Capital expenditure reported	24.16%-285.9M	27.45%-76.1M	22.14%-63.3M	24.95%-75.2M	21.30%-71.3M	-4.14%-377M	3.50%-104.9M	15.14%-81.3M	-32.89%-100.2M	-10.35%-90.6M
Net other investing changes	----	----	----	----	----	74.63%-1.7M	200.00%100K	-900.00%-800K	----	----
Cash from discontinued investing activities
Investing cash flow	24.50%-285.9M	27.39%-76.1M	22.90%-63.3M	25.69%-75.2M	21.30%-71.3M	-2.71%-378.7M	3.68%-104.8M	14.21%-82.1M	-23.26%-101.2M	-10.35%-90.6M
Financing cash flow
Cash flow from continuing financing activities	70.27%-185.1M	83.02%-11.7M	82.14%-11.5M	93.17%-14.9M	45.76%-147M	-35.47%-622.6M	63.64%-68.9M	-188.79%-64.4M	-23.47%-218.3M	-281.69%-271M
Net issuance payments of debt	96.01%-1.1M	-200.00%-300K	91.43%-300K	98.71%-300K	71.43%-200K	-1,050.00%-27.6M	85.71%-100K	-483.33%-3.5M	-4,560.00%-23.3M	-16.67%-700K
Net common stock issuance	75.86%-136.8M	99.63%-200K	99.81%-100K	99.73%-500K	50.07%-136M	-25.58%-566.6M	69.17%-54.6M	-86.48%-52.4M	-7.34%-187.2M	-280.45%-272.4M
Cash dividends paid	-3.55%-61.2M	-3.27%-15.8M	-4.14%-15.1M	-3.42%-15.1M	-3.40%-15.2M	-3.68%-59.1M	-3.38%-15.3M	-3.57%-14.5M	-3.55%-14.6M	-4.26%-14.7M
Proceeds from stock option exercised by employees	-44.34%18.2M	48.39%4.6M	-33.33%4M	-23.53%5.2M	-73.81%4.4M	-35.88%32.7M	0.00%3.1M	-70.59%6M	-44.26%6.8M	9.80%16.8M
Net other financing activities	-110.00%-4.2M	--0	--0	----	----	---2M	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	70.27%-185.1M	83.02%-11.7M	82.14%-11.5M	93.17%-14.9M	45.76%-147M	-35.47%-622.6M	63.64%-68.9M	-188.79%-64.4M	-23.47%-218.3M	-281.69%-271M
Net cash flow
Beginning cash position	-43.25%484.6M	28.03%628.5M	14.23%509.7M	-32.83%404.2M	-43.25%484.6M	-4.52%853.9M	-45.37%490.9M	-43.97%446.2M	-32.10%601.8M	-4.52%853.9M
Current changes in cash	181.58%283.8M	895.73%163.3M	264.29%122.4M	156.31%87M	63.48%-88.9M	-571.62%-347.9M	127.70%16.4M	-70.03%33.6M	-72.24%-154.5M	-1,522.67%-243.4M
Effect of exchange rate changes	207.01%22.9M	97.80%-500K	-132.43%-3.6M	1,781.82%18.5M	197.70%8.5M	-287.72%-21.4M	-256.55%-22.7M	213.27%11.1M	-266.67%-1.1M	-224.29%-8.7M
End cash Position	63.29%791.3M	63.29%791.3M	28.03%628.5M	14.23%509.7M	-32.83%404.2M	-43.25%484.6M	-43.25%484.6M	-45.37%490.9M	-43.97%446.2M	-32.10%601.8M
Free cash flow	69.65%468.9M	105.40%175M	35.53%133.9M	57.25%101.9M	110.51%58.1M	-33.32%276.4M	-34.66%85.2M	-26.43%98.8M	-30.92%64.8M	-50.71%27.6M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm